Why this grouping
The members are kept as separate Disease entries because their proximal mechanisms differ: AGXT and GRHPR are hepatic glyoxylate-metabolism enzyme defects with endogenous oxalate overproduction; HAO1 deficiency is a glycolate oxidase defect that primarily causes hyperglycolic aciduria; and SLC26A1/SLC26A6 are oxalate/anion transporter disorders. A grouping is useful because all five belong to the ICIMD glyoxylate-and-oxalate pathway bucket and share downstream concern for oxalate or calcium oxalate handling, while CAT catalase deficiency is intentionally excluded because it disrupts hydrogen peroxide metabolism instead.
Membership criteria
NECESSARY (member ⇒ criteria)
A member has a primary genetic defect in a glyoxylate/glycolate metabolic enzyme or an oxalate/anion transporter that materially changes oxalate, glycolate, glyoxylate, or calcium oxalate handling.
- OR
- HAS GENE
AGXT hgnc:341
AGXT/alanine-glyoxylate aminotransferase defect.
- HAS GENE
GRHPR hgnc:4570
GRHPR/glyoxylate reductase-hydroxypyruvate reductase defect.
- HAS GENE
HOGA1 hgnc:25155
HOGA1/4-hydroxy-2-oxoglutarate aldolase defect.
- HAS GENE
HAO1 hgnc:4809
HAO1/glycolate oxidase defect.
- HAS GENE
SLC26A1 hgnc:10993
SLC26A1/SAT1 anion transporter defect.
- HAS GENE
SLC26A6 hgnc:14472
SLC26A6 epithelial oxalate transporter defect.
- HAS GENE
AGXT hgnc:341
Coverage and gaps
6 rows
Exact MONDO scope not assessed
4 listed with MONDO ID
2 DisMech outside/no MONDO
No exact MONDO mapping is declared, so MONDO descendant gaps are not inferred for this grouping.
| Status | DisMech entry | MONDO concept | In DisMech | Has MONDO ID | In grouping MONDO | Member state | Conditions satisfied | C1.1 AGXT/alanine-glyoxylate aminotransferase defect. hgnc:341 | C1.2 GRHPR/glyoxylate reductase-hydroxypyruvate reductase defect. hgnc:4570 | C1.3 HOGA1/4-hydroxy-2-oxoglutarate aldolase defect. hgnc:25155 | C1.4 HAO1/glycolate oxidase defect. hgnc:4809 | C1.5 SLC26A1/SAT1 anion transporter defect. hgnc:10993 | C1.6 SLC26A6 epithelial oxalate transporter defect. hgnc:14472 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| listed with MONDO ID |
SLC26A1-Related Oxalate Transporter Deficiency
DISEASE
Differentiating mechanismBiallelic SLC26A1/SAT1 variants reduce anion transporter activity and cause a recessive Mendelian calcium oxalate nephrolithiasis phenotype.
SLC26A1 hgnc:10993oxalate transport GO:0019532
|
nephrolithiasis susceptibility caused by SLC26A1
MONDO:0020722
|
yes | yes | not assessed | listed | satisfied | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | SATISFIED | NOT SATISFIED |
| listed with MONDO ID |
Primary Hyperoxaluria Type 1
DISEASE
Differentiating mechanismAGXT deficiency blocks hepatic peroxisomal glyoxylate-to-glycine transamination, diverting glyoxylate to oxalate and causing severe endogenous hyperoxaluria.
AGXT hgnc:341glyoxylate metabolic process GO:0046487
|
primary hyperoxaluria type 1
MONDO:0009823
|
yes | yes | not assessed | listed | satisfied | SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED |
| listed with MONDO ID |
Primary Hyperoxaluria Type 2
DISEASE
Differentiating mechanismGRHPR deficiency impairs glyoxylate-to-glycolate and hydroxypyruvate-to-D-glycerate flux, producing increased urinary oxalate and L-glycerate.
GRHPR hgnc:4570glyoxylate metabolic process GO:0046487
|
primary hyperoxaluria type 2
MONDO:0009824
|
yes | yes | not assessed | listed | satisfied | NOT SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED |
| listed with MONDO ID |
Primary Hyperoxaluria Type 3
DISEASE
Differentiating mechanismHOGA1 deficiency blocks the final mitochondrial step of hepatic hydroxyproline degradation (4-hydroxy-2-oxoglutarate aldolase), causing accumulation of 4-hydroxy-2-oxoglutarate and increased endogenous oxalate; PH3 is generally the mildest primary hyperoxaluria with rare progression to kidney failure.
HOGA1 hgnc:25155glyoxylate metabolic process GO:0046487
|
primary hyperoxaluria type 3
MONDO:0013327
|
yes | yes | not assessed | listed | satisfied | SATISFIED | NOT SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED |
| DisMech only |
HAO1-Related Glycolate Oxidase Deficiency
DISEASE
Differentiating mechanismHAO1/glycolate oxidase deficiency reduces glycolate oxidation to glyoxylate, causing isolated hyperglycolic aciduria and generally benign biochemical disease rather than established recurrent calcium oxalate nephrolithiasis.
HAO1 hgnc:4809glyoxylate metabolic process GO:0046487
|
No MONDO identity | yes | no | not assessed | listed | satisfied | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | SATISFIED | NOT SATISFIED | NOT SATISFIED |
| DisMech only |
SLC26A6-Related Hyperoxaluria and Nephrolithiasis
DISEASE
Differentiating mechanismA rare dominant-negative SLC26A6 variant reduces epithelial oxalate transport, causing enteric hyperoxaluria and calcium oxalate nephrolithiasis in the reported family.
SLC26A6 hgnc:14472oxalate transport GO:0019532
|
No MONDO identity | yes | no | not assessed | listed | satisfied | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | NOT SATISFIED | SATISFIED |
Source
View YAML on GitHubRaw YAML
name: Disorders of Glyoxylate and Oxalate Metabolism
display_name: Disorders of Glyoxylate and Oxalate Metabolism
creation_date: "2026-07-06T06:09:44Z"
description: >-
An auditable grouping of distinct DisMech disease entries whose primary
defect disrupts glyoxylate, glycolate, oxalate, or calcium oxalate handling.
Members include hepatic enzyme deficiencies that overproduce oxalate,
HAO1/glycolate oxidase deficiency upstream of glyoxylate production, and
transporter defects that alter oxalate handling and calcium oxalate stone
risk.
grouping_basis:
- SHARED_PATHWAY
- SHARED_MECHANISM
grouping_rationale: >-
The members are kept as separate Disease entries because their proximal
mechanisms differ: AGXT and GRHPR are hepatic glyoxylate-metabolism enzyme
defects with endogenous oxalate overproduction; HAO1 deficiency is a
glycolate oxidase defect that primarily causes hyperglycolic aciduria; and
SLC26A1/SLC26A6 are oxalate/anion transporter disorders. A grouping is useful
because all five belong to the ICIMD glyoxylate-and-oxalate pathway bucket and
share downstream concern for oxalate or calcium oxalate handling, while CAT
catalase deficiency is intentionally excluded because it disrupts hydrogen
peroxide metabolism instead.
membership_criteria:
- description: >-
A member has a primary genetic defect in a glyoxylate/glycolate metabolic
enzyme or an oxalate/anion transporter that materially changes oxalate,
glycolate, glyoxylate, or calcium oxalate handling.
criteria_semantics: NECESSARY
logic:
operator: OR
operands:
- criterion_predicate: HAS_GENE
gene:
preferred_term: AGXT
term:
id: hgnc:341
label: AGXT
description: AGXT/alanine-glyoxylate aminotransferase defect.
- criterion_predicate: HAS_GENE
gene:
preferred_term: GRHPR
term:
id: hgnc:4570
label: GRHPR
description: GRHPR/glyoxylate reductase-hydroxypyruvate reductase defect.
- criterion_predicate: HAS_GENE
gene:
preferred_term: HOGA1
term:
id: hgnc:25155
label: HOGA1
description: HOGA1/4-hydroxy-2-oxoglutarate aldolase defect.
- criterion_predicate: HAS_GENE
gene:
preferred_term: HAO1
term:
id: hgnc:4809
label: HAO1
description: HAO1/glycolate oxidase defect.
- criterion_predicate: HAS_GENE
gene:
preferred_term: SLC26A1
term:
id: hgnc:10993
label: SLC26A1
description: SLC26A1/SAT1 anion transporter defect.
- criterion_predicate: HAS_GENE
gene:
preferred_term: SLC26A6
term:
id: hgnc:14472
label: SLC26A6
description: SLC26A6 epithelial oxalate transporter defect.
members:
- member: Primary Hyperoxaluria Type 1
member_type: DISEASE
disease_term:
preferred_term: primary hyperoxaluria type 1
term:
id: MONDO:0009823
label: primary hyperoxaluria type 1
differentiating_mechanisms:
- description: >-
AGXT deficiency blocks hepatic peroxisomal glyoxylate-to-glycine
transamination, diverting glyoxylate to oxalate and causing severe
endogenous hyperoxaluria.
gene:
preferred_term: AGXT
term:
id: hgnc:341
label: AGXT
biological_processes:
- preferred_term: glyoxylate metabolic process
term:
id: GO:0046487
label: glyoxylate metabolic process
modifier: DYSREGULATED
- member: Primary Hyperoxaluria Type 2
member_type: DISEASE
disease_term:
preferred_term: primary hyperoxaluria type 2
term:
id: MONDO:0009824
label: primary hyperoxaluria type 2
differentiating_mechanisms:
- description: >-
GRHPR deficiency impairs glyoxylate-to-glycolate and
hydroxypyruvate-to-D-glycerate flux, producing increased urinary oxalate
and L-glycerate.
gene:
preferred_term: GRHPR
term:
id: hgnc:4570
label: GRHPR
biological_processes:
- preferred_term: glyoxylate metabolic process
term:
id: GO:0046487
label: glyoxylate metabolic process
modifier: DYSREGULATED
- member: Primary Hyperoxaluria Type 3
member_type: DISEASE
disease_term:
preferred_term: primary hyperoxaluria type 3
term:
id: MONDO:0013327
label: primary hyperoxaluria type 3
differentiating_mechanisms:
- description: >-
HOGA1 deficiency blocks the final mitochondrial step of hepatic
hydroxyproline degradation (4-hydroxy-2-oxoglutarate aldolase), causing
accumulation of 4-hydroxy-2-oxoglutarate and increased endogenous oxalate;
PH3 is generally the mildest primary hyperoxaluria with rare progression
to kidney failure.
gene:
preferred_term: HOGA1
term:
id: hgnc:25155
label: HOGA1
biological_processes:
- preferred_term: glyoxylate metabolic process
term:
id: GO:0046487
label: glyoxylate metabolic process
modifier: DYSREGULATED
- member: HAO1-Related Glycolate Oxidase Deficiency
member_type: DISEASE
differentiating_mechanisms:
- description: >-
HAO1/glycolate oxidase deficiency reduces glycolate oxidation to
glyoxylate, causing isolated hyperglycolic aciduria and generally benign
biochemical disease rather than established recurrent calcium oxalate
nephrolithiasis.
gene:
preferred_term: HAO1
term:
id: hgnc:4809
label: HAO1
biological_processes:
- preferred_term: glyoxylate metabolic process
term:
id: GO:0046487
label: glyoxylate metabolic process
modifier: DECREASED
- member: SLC26A1-Related Oxalate Transporter Deficiency
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Biallelic SLC26A1/SAT1 variants reduce anion transporter activity and
cause a recessive Mendelian calcium oxalate nephrolithiasis phenotype.
gene:
preferred_term: SLC26A1
term:
id: hgnc:10993
label: SLC26A1
biological_processes:
- preferred_term: oxalate transport
term:
id: GO:0019532
label: oxalate transport
modifier: DECREASED
- member: SLC26A6-Related Hyperoxaluria and Nephrolithiasis
member_type: DISEASE
differentiating_mechanisms:
- description: >-
A rare dominant-negative SLC26A6 variant reduces epithelial oxalate
transport, causing enteric hyperoxaluria and calcium oxalate
nephrolithiasis in the reported family.
gene:
preferred_term: SLC26A6
term:
id: hgnc:14472
label: SLC26A6
biological_processes:
- preferred_term: oxalate transport
term:
id: GO:0019532
label: oxalate transport
modifier: DECREASED
notes: >-
Created for WP-032 to make the package boundary auditable without lumping
distinct enzyme and transporter defects into one Disease entry.